Welcome to our dedicated page for Schrodinger SEC filings (Ticker: SDGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Schrödinger, Inc. (SDGR) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, alongside AI-powered tools that help interpret key documents. As a Nasdaq-listed issuer, Schrödinger files current reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q, among other documents, to provide transparency into its operations, governance and financial condition.
Recent Form 8-K filings illustrate the range of topics covered in SDGR’s regulatory reporting. The company has furnished press releases announcing quarterly financial results under Item 2.02, giving detail on software revenue, drug discovery revenue, software gross margin, operating expenses, cash position and non-GAAP measures. Other 8-K filings describe matters such as the submission of proposals to stockholders at the annual meeting, voting outcomes for director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
Schrödinger has also used Form 8-K to disclose executive compensation and separation arrangements under Item 5.02, including a separation and release of claims agreement with a former executive vice president and chief financial officer. These filings outline severance-related payments, equity vesting terms, COBRA-related benefits and other contractual provisions, providing insight into the company’s executive compensation framework.
On Stock Titan, users can review SDGR’s 10-K and 10-Q filings for detailed discussions of its software and drug discovery activities, risk factors, segment information and accounting policies. AI-powered summaries help explain lengthy filings by highlighting important sections, such as revenue breakdowns between software and drug discovery, non-GAAP reconciliations and disclosures related to collaborations and equity investments. The platform also surfaces Form 4 insider transaction reports, allowing users to track equity awards and share transactions by directors and officers.
With real-time updates from EDGAR and AI-generated overviews, the Schrödinger SEC filings page is intended to make it easier to navigate complex regulatory documents, compare periods and understand how SDGR’s computational platform, collaborations and therapeutics portfolio are reflected in its official disclosures.
On 18 June 2025, Schrödinger, Inc. (SDGR) filed a Form 4 reporting routine director compensation for board member Gary L. Ginsberg. The award package comprises:
- 5,997 restricted stock units (RSUs) granted at no cost; each RSU converts into one common share when settled.
- Stock options for 9,341 shares with a $21.05 exercise price.
Both the RSUs and the options vest on the earlier of (i) the 12-month anniversary of the 18 Jun 2025 grant date or (ii) the next annual shareholder meeting, subject to Ginsberg’s continued board service. Settlement of vested RSUs is deferred until the earlier of (a) 30 days after separation from service or (b) specific change-in-control events.
Following the grant, Ginsberg’s direct beneficial ownership rises to 17,247 common shares (including the newly issued 5,997 unvested RSUs) plus the newly granted option rights. No shares were sold or disposed of, and all transactions were executed at $0 cash cost to the company or insider.
The filing, signed 20 Jun 2025, reflects normal annual director equity awards under the company’s 2022 Equity Incentive Plan and is not expected to have a material impact on Schrödinger’s capital structure or near-term financials.
Schrödinger, Inc. (SDGR) – Form 4 insider filing dated 20-Jun-2025
Director Arun Oberoi reported two equity awards granted on 18-Jun-2025 under the company’s 2022 Equity Incentive Plan:
- 5,997 Restricted Stock Units (RSUs) (Transaction code “A”, price $0). All RSUs vest on the earlier of 12-month anniversary or the next annual shareholder meeting, subject to continued service.
- 9,341 stock options with an exercise price of $21.05, expiring 18-Jun-2035. The option vesting schedule mirrors the RSUs.
After the grant, Oberoi’s direct beneficial ownership increases to 17,247 common shares, which includes the 5,997 unvested RSUs. No shares were sold or disposed of; the filing reflects a routine, non-cash compensation grant intended to align director incentives with shareholder interests. The incremental dilution is de-minimis in the context of Schrödinger’s total share count and is unlikely to materially affect valuation.
Schrodinger, Inc. (SDGR) – Form 4 insider filing dated 20 June 2025
Director Dr. Richard Friesner reported routine equity awards granted on 18 June 2025 under the company’s 2022 Equity Incentive Plan.
- Restricted stock units (RSUs): 5,997 units awarded at no cost. Each RSU converts into one common share. Vesting occurs on the twelve-month anniversary of grant or the date of the next annual shareholders’ meeting, whichever comes first. Settlement is deferred until the earlier of 30 days after the director leaves the company or a qualifying change-of-control event.
- Stock options: right to purchase 9,341 common shares at an exercise price of $21.05. The options share the same vesting trigger and carry a 10-year term, expiring 18 June 2035.
Post-transaction ownership
- Direct: 521,697 shares (includes the 5,997 unvested RSUs)
- Indirect: 694,925 shares held by a 2018 Grantor Retained Annuity Trust and 28,328 shares held by the director’s spouse
- Total beneficial ownership: ≈1.245 million shares
Implications for investors: The filing shows no dispositions; all reported codes are “A” (acquisitions), indicating incentive alignment rather than open-market sentiment. The size of the award is immaterial relative to SDGR’s total shares outstanding and therefore unlikely to move the stock on its own. Nevertheless, continued significant insider ownership can be viewed as a governance positive.
Schrödinger, Inc. (Nasdaq: SDGR) filed an 8-K disclosing the voting results of its 2025 Annual Meeting held on 18 June 2025. Shareholders acted on three routine corporate-governance items.
- Board elections (Proposal 1): All four Class II directors—Jeffrey Chodakewitz, Michael Lynton, Nancy A. Thornberry and Bridget van Kralingen—were re-elected for terms ending at the 2028 meeting. Support ranged from 73% to 99%, with Michael Lynton receiving the lowest approval (32.4 million “For” versus 12.3 million “Against,” or c. 27.5% opposition).
- Say-on-Pay (Proposal 2): The non-binding advisory vote on executive compensation passed with 50.8 million votes For and 3.0 million Against (≈94.4% support when limited and common stock are combined).
- Auditor ratification (Proposal 3): KPMG LLP was reaffirmed as independent auditor for FY 2025 with 61.4 million votes For and only 0.3 million Against (≈99.5% support).
No other material transactions, earnings data, or strategic changes were reported in this filing.